[go: up one dir, main page]

NO974320L - Fucopeptider - Google Patents

Fucopeptider

Info

Publication number
NO974320L
NO974320L NO974320A NO974320A NO974320L NO 974320 L NO974320 L NO 974320L NO 974320 A NO974320 A NO 974320A NO 974320 A NO974320 A NO 974320A NO 974320 L NO974320 L NO 974320L
Authority
NO
Norway
Prior art keywords
peptide residue
fucopeptider
selectins
mimetics
precursors
Prior art date
Application number
NO974320A
Other languages
English (en)
Other versions
NO974320D0 (no
Inventor
Tetsuya Kajimoto
Chi-Huey Wong
Chun-Cheng Lin
Original Assignee
Ciba Geigy Ag
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/407,912 external-priority patent/US5599915A/en
Application filed by Ciba Geigy Ag, Scripps Research Inst filed Critical Ciba Geigy Ag
Publication of NO974320D0 publication Critical patent/NO974320D0/no
Publication of NO974320L publication Critical patent/NO974320L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Forbindelser med formel I \ UH OH hvor R er CHj og Rj er en peptidrest eller Ri er OH og R er en peptidrest, har farmasøytisk aktivitet som sialyl Lewis X mimetika, for eksempel i forhindring eller behandling av forstynelser eller sykdommer som er mediert ved binding av selektiner i cellulær adhesjon.
NO974320A 1995-03-21 1997-09-19 Fucopeptider NO974320L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/407,912 US5599915A (en) 1995-03-21 1995-03-21 Sialyl Lewis X mimetics
US08/519,203 US5614615A (en) 1995-03-21 1995-08-25 Sialyl Lewis X mimetics incorporating fucopeptides
PCT/EP1996/001244 WO1996029339A1 (en) 1995-03-21 1996-03-21 Fucopeptides

Publications (2)

Publication Number Publication Date
NO974320D0 NO974320D0 (no) 1997-09-19
NO974320L true NO974320L (no) 1997-10-27

Family

ID=27020064

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974320A NO974320L (no) 1995-03-21 1997-09-19 Fucopeptider

Country Status (17)

Country Link
US (3) US5614615A (no)
EP (1) EP0815127A1 (no)
JP (1) JPH11502216A (no)
KR (1) KR19980703171A (no)
CN (1) CN1184483A (no)
AU (1) AU5147496A (no)
BR (1) BR9607795A (no)
CA (1) CA2214107A1 (no)
CZ (1) CZ294597A3 (no)
FI (1) FI973503L (no)
HU (1) HUP9801128A3 (no)
NO (1) NO974320L (no)
NZ (1) NZ304317A (no)
PL (1) PL322361A1 (no)
SK (1) SK127797A3 (no)
TR (1) TR199700974T1 (no)
WO (1) WO1996029339A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277975B1 (en) * 1992-10-23 2001-08-21 Genetics Institute, Inc. Fusions of P-selectin ligand protein and polynucleotides encoding same
WO1995013094A1 (en) * 1993-11-10 1995-05-18 Bristol-Myers Squibb Company Treatment of bacterially-induced inflammatory diseases
US5614615A (en) * 1995-03-21 1997-03-25 The Scripps Research Institute Sialyl Lewis X mimetics incorporating fucopeptides
WO1999010359A2 (en) * 1997-08-26 1999-03-04 Novartis Ag Liposomic based sialyl lewis x mimetics
CN1342085A (zh) * 1998-10-30 2002-03-27 遗传研究所有限公司 通过p－选择素配体(psgl)拮抗剂抑制细胞素t细胞的分化
US6960566B1 (en) * 1998-11-06 2005-11-01 The Wister Institute of Anatomy and Biology Compositions and methods for treatment of cancer
UA75083C2 (uk) 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
DE10056136A1 (de) * 2000-11-07 2002-05-16 Nemod New Modalities Verwendung von Schwangerschaftsproteinen, Liposomen, nativen Muzin-Fragmenten und Mimikry-Verbindungen zur Behandlung und Prophylaxe von entzündlichen Erkrankungen, zur Verhinderung der Metastasierung und zur Prophylaxe von Tumorerkrankungen
FR2861729B1 (fr) 2003-10-31 2006-09-08 Fabre Pierre Dermo Cosmetique Monomere d'alkyl-rhamnose ou d'alkyl-fucose, medicament comprenant un monomere d'alkyl-sucre reducteur
GB0426661D0 (en) * 2004-12-06 2005-01-05 Isis Innovation Pyrrolidine compounds
FR2899464B1 (fr) * 2006-04-07 2008-06-06 Oreal Compose c-glycoside et utilisation comme agent activateur et regulateur de l'immunite cutanee
FR2899463B1 (fr) * 2006-04-07 2008-05-30 Oreal Utilisation dej compose c-glycoside comme agent activateur et regulateur de l'immunite cutanee
ES2324137B2 (es) * 2007-11-14 2010-02-12 Universidad De Sevilla Tiofucosidos conteniendo prolinas hidroxiladas. sintesis y usos de los mismos.
ES2325567B2 (es) * 2007-11-14 2010-02-12 Universidad De Sevilla Tiofucosidos conteniendo polihidroxialquil-furanos. sintesis y usos delos mismos.
FR2951377B1 (fr) 2009-10-21 2012-06-22 Oreal Association d'un lysat de probiotique et d'un derive c-glycoside
JP6605201B2 (ja) * 2014-12-31 2019-11-13 公益財団法人野口研究所 糖アミノ酸誘導体または糖ペプチド誘導体の製造方法
CN107011203B (zh) * 2017-04-28 2019-03-29 江苏阿尔法药业有限公司 一种lcz696中间体ahu-377的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3871958A (en) * 1972-03-04 1975-03-18 Ajinomoto Kk Biological method of producing serine and serinol derivatives
US5079353A (en) * 1987-12-02 1992-01-07 Chembiomed, Ltd. Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation
AU8007791A (en) * 1990-06-15 1992-01-07 Cytel Corporation Intercellular adhesion mediators
US5143712A (en) * 1990-07-30 1992-09-01 Glycomed Incorporated Method of determining a site of inflammation utilizing elam-1 ligands
US5508387A (en) * 1993-08-04 1996-04-16 Glycomed Incorporated Selectin binding glycopeptides
US5614615A (en) * 1995-03-21 1997-03-25 The Scripps Research Institute Sialyl Lewis X mimetics incorporating fucopeptides
US5599915A (en) * 1995-03-21 1997-02-04 The Scripps Research Institute Sialyl Lewis X mimetics

Also Published As

Publication number Publication date
US5614615A (en) 1997-03-25
HUP9801128A2 (hu) 1998-09-28
CZ294597A3 (en) 1997-12-17
WO1996029339A1 (en) 1996-09-26
FI973503A0 (fi) 1997-08-26
TR199700974T1 (xx) 1998-02-21
PL322361A1 (en) 1998-01-19
US5962660A (en) 1999-10-05
HUP9801128A3 (en) 1999-06-28
JPH11502216A (ja) 1999-02-23
MX9707158A (es) 1998-07-31
FI973503A7 (fi) 1997-11-21
BR9607795A (pt) 1998-07-07
NZ304317A (en) 1999-01-28
US6111084A (en) 2000-08-29
FI973503L (fi) 1997-11-21
AU5147496A (en) 1996-10-08
CN1184483A (zh) 1998-06-10
KR19980703171A (ko) 1998-10-15
SK127797A3 (en) 1998-02-04
NO974320D0 (no) 1997-09-19
CA2214107A1 (en) 1996-09-26
EP0815127A1 (en) 1998-01-07

Similar Documents

Publication Publication Date Title
NO974320L (no) Fucopeptider
ZA987087B (en) Chemical compounds
AP9701041A0 (en) Pyridylpyrrole compounds.
CA2407100A1 (en) 1-aroyl-piperidinyl benzamidines
DE69831868D1 (en) Antithrombosemittel
IL133623A0 (en) Antithrombotic agents
EP0675899A4 (en) NEW INHIBITORS FROM FACTOR Xa.
BG106340A (en) Substituted oxoazaheterocyclyl compounds
MY119350A (en) Propiophenone derivatives and process for preparing the same
RU94036772A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования эндометриоза
CA2152486A1 (en) Anticonvulsant sorbopyranose sulfamates
LU91145I9 (no)
NZ312840A (en) Ketoheterocyclic inhibitors of factor Xa
BR9508196A (pt) Composto uso de compostos composição farmacêutica e processo para tratamento de doenças inflamatórias em hospedeiro
MX9800189A (es) Compuestos y composiciones farmaceuticas que los contienen.
CA2040905A1 (en) Carbohydrate derivatives comprising a trisaccharide unit
MX9708696A (es) Cefalosporinas antibacterianas.
MX9804046A (es) 6-0-metil eritromicina d y proceso para hacerla.
GR3030733T3 (en) Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them
AU1306795A (en) Anticonvulsant pseudofructopyranose sulfamates
UA41871C2 (uk) Похідні еритроміцину, спосіб їх одержання та фармацевтична композиція на їх основі
UA48962C2 (uk) Біциклічні антагоністи тахікінінів, фармацевтична композиція та спосіб лікування
AU6306190A (en) Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides